Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.

PLoS One · 2018 · PMC5886396 · PMID 29621248

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Nonetheless, the results of the present study are promising for reducing the risk of stroke in NVAF patients considering that it has previously been suggested that a 3% to 6% percentage point change in adherence is likely to be significant among patients with high-risk conditions.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.